Goldman Sachs
AGN

Goldman Sachs’s Allergan plc AGN Stock Holding History

Goldman Sachs’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-75,000
Closed -$13.3M – 5659
2020
Q1 		$13.3M Buy
75,000
+38,700
+107% +$7.29M ﹤0.01% 1843
2019
Q4 		$6.94M Buy
36,300
+28,300
+354% +$5.11M ﹤0.01% 2706
2019
Q3 		$1.35M Sell
8,000
-50,300
-86% -$8.19M ﹤0.01% 3815
2019
Q2 		$9.76M Buy
58,300
+22,600
+63% +$3.13M ﹤0.01% 2375
2019
Q1 		$5.23M Sell
35,700
-56,400
-61% -$8.18M ﹤0.01% 2933
2018
Q4 		$12.3M Buy
92,100
+16,900
+22% +$2.77M ﹤0.01% 2185
2018
Q3 		$14.3M Buy
75,200
+8,600
+13% +$1.58M ﹤0.01% 2168
2018
Q2 		$11.1M Sell
66,600
-65,600
-50% -$10.5M ﹤0.01% 2328
2018
Q1 		$22.2M Sell
132,200
-423,000
-76% -$71M 0.01% 1775
2017
Q4 		$90.8M Sell
555,200
-378,700
-41% -$68M 0.02% 857
2017
Q3 		$191M Sell
933,900
-399,700
-30% -$93M 0.05% 450
2017
Q2 		$324M Sell
1,333,600
-2,316,100
-63% -$544M 0.08% 227
2017
Q1 		$872M Buy
3,649,700
+1,117,824
+44% +$260M 0.24% 60
2016
Q4 		$532M Buy
2,531,876
+481,000
+23% +$99.6M 0.15% 107
2016
Q3 		$472M Sell
2,050,876
-170,500
-8% -$41.7M 0.14% 109
2016
Q2 		$513M Sell
2,221,376
-370,000
-14% -$85.3M 0.17% 87
2016
Q1 		$695M Sell
2,591,376
-693,133
-21% -$198M 0.23% 59
2015
Q4 		$1.03B Buy
3,284,509
+2,753,000
+518% +$820M 0.32% 33
2015
Q3 		$144M Buy
531,509
+431,900
+434% +$133M 0.05% 441
2015
Q2 		$30.2M Sell
99,609
-1,575,056
-94% -$470M 0.01% 1498
2015
Q1 		$498M Buy
1,674,665
+613,578
+58% +$175M 0.16% 114
2014
Q4 		$273M Buy
1,061,087
+750,647
+242% +$188M 0.09% 249
2014
Q3 		$74.9M Sell
310,440
-94,596
-23% -$21.2M 0.02% 802
2014
Q2 		$90.3M Buy
405,036
+146,940
+57% +$30.4M 0.03% 720
2014
Q1 		$53.1M Buy
258,096
+223,432
+645% +$44.3M 0.02% 1018
2013
Q4 		$5.82M Buy
34,664
+25,464
+277% +$3.98M ﹤0.01% 2907
2013
Q3 		$1.32M Sell
9,200
-54,600
-86% -$7.27M ﹤0.01% 4333
2013
Q2 		$8.05M Buy
+63,800
New +$7.22M ﹤0.01% 2282

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Goldman Sachs's AGN Position: Q2 2020 in Review

Goldman Sachs sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,490,686 shares — an estimated $1.33B sold.

Goldman Sachs first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.45B in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Goldman Sachs reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Goldman Sachs sold 7,490,686 Allergan plc shares in Q2 2020, an estimated $1.33B.
  • Goldman Sachs first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Goldman Sachs's Allergan plc position peaked at $1.45B in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.